Babesia parasites are responsible for enormous economic losses to the livestock industry worldwide. There is no vaccine available to protect from the infection. RNA interference (RNAi) has emerged as a simple and incisive technique to study gene functions in a variety of organisms. In this study, we evaluated the effects of RNAi by double-stranded RNA (dsRNA) of the DNA gyrase subunits A and B, the DNA-directed RNA polymerase beta subunit (rpo B), and thiostrepton interaction site (ribosomal L11 protein) genes on the in vitro growth of Babesia bovis. The inhibitory effects produced by dsRNAs of DNA gyrase subunit A, DNA gyrase subunit B, thiostrepton interaction site (L11) and the DNA-directed RNA polymerase beta subunit (rpo B1and B2) were compared with the effect of drugs target these genes. RNAi directed towards these genes resulted in inhibition of in vitro growth of the parasite. The RT-PCR showed that parasites treated with dsRNAs of DNA gyrase subunit A, DNA gyrase subunit B, ribosomal L11, and the DNA-directed RNA polymerase beta subunit (rpo B1 and B2) have blocked expression of corresponding endogenous mRNAs of DNA gyrase subunit A, DNA gyrase B, ribosomal L11, and rpo B genes. These results demonstrate that the RNAi technique disrupted gene function in B. bovis and the mechanism of action required further studies to be elucidated. B, ribosomal L11 protein, DNA directed RNA polymerase subunit B (rpo B) part 1 (rpo B1) and part 2 (rpo B2), and GFP. Lane 1, GFP dsRNA; lane 2, gyrase A dsRNA; lane 3, gyrase B dsRNA; lane 4, L11 protein dsRNA; lane 5, rpo B1 dsRNA; lane 6, rpo B2 dsRNA. M is molecular weight marker.
INTRODUCTION
Babesia parasites are tick-transmitted protozoa. They affect a wide variety of animals and are responsible for enormous economic losses to the livestock industry worldwide (Kuttler, 1988) . Moreover, Babesia divergens and Babesia microti have zoonotic importance for human (Krause, 2003) . No vaccine was developed for controlling the infection. On the other hand, live Babesia vaccines attenuated by passage through splenectomized cattle resulted in immunity to the vaccinated animals. However, live vaccines have risk, which includes transmission of render pest and vaccination failure (De Vos and Bock, 2000) . Several babesicidal drugs that have been in use for years have proven to be ineffective owing to problems related to their toxicity and the development of resistant parasites (Vial and Gorenflot, 2006) . Therefore, there is a need to develop new methods for controlling the infection caused by Babesia parasites. One of the direct ways to determine the biological function of a protein is to knock out the gene by homologous recombination. In recent years, methodologies have been developed that permit transfection of Plasmodium falciparum (Waters et al., 1997) and Babesia bovis (Suarez et al., 2007; McElwain, 2008, 2009; Asada et al., 2012; Pedroni et al., 2012) as well as the deletion of specific genes in order to study their function in Plasmodium falciparum (Waters et al., 1997) and in B. bovis (Asada et al., 2012) . However, Babesia transfection studies is still in the beginning (Suarez and McElwain, 2010) . RNA interference (RNAi) has emerged as a powerful method for studying gene functions in a wide range of organisms. The term RNAi refers to the sequence-specific degradation of mRNA by its homologous double-stranded RNA (dsRNA) (Fire, 1999) . Similar phenomena to RNAi have been known for many years in plants, called post-transcriptional gene silencing (PTGS) (Hamilton and Baulcombe, 1999) and in fungi, called 'quelling' (Cogoni et al., 1996) . RNAi was first demonstrated in nematodes (Fire, 1999) and was later demonstrated in both unicellular organisms such as Trypanosoma brucei, Plasmodium falciparum, and Toxoplasma gondii (Malhotra et al., 2002; Ngo et al., 1998; Yu et al., 2009 ) and multicellular organisms such as ticks (Hatta et al., 2007) , Brugia malayi, Caenorhabditis elegans, Drosophila, Planaria, Hydra, zebra fish, and mouse (Aboobaker and Blaxter, 2003; Cogoni and Macino, 2000; Maeda et al., 2001) . RNAi was applied successfully to study the functions of a large number of genes on a genomic scale in C. elegans (Maeda et al., 2001) . Babesia bovis apicoplast is a circular 33 kbp genome and unidirectionally encodes 32 putative protein coding genes, a complete set of tRNA genes, and a small and large subunit rRNA gene as observed with other apicoplast genomes (Brayton et al., 2007) . The apicoplast in the apicomplexan parasites, Plasmodium falciparum, Toxoplasma gondii, and Babesia, has typical bacterial housekeeping machinery such as DNA replication, transcription, translation (McConkey et al., 1997) . DNA gyrase is a prokaryotic type II topoisomerase involved in untangling DNA during replication. DNA gyrase is nuclear encoded and formed of 2 subunits, DNA gyrase subunit A and DNA gyrase subunit B. Ciprofloxacin blocks the prokaryotic DNA replication by inhibiting DNA gyrase and results in linearization of the circular DNA, thus causing death of prokaryotic organisms (Onodera et al., 2001) . Rpo B gene is coding for DNAdirected RNA polymerase beta subunit in the apicoplast. Rifampicin blocks bacterial type transcription and abrogates mRNA production by the apicoplast-encoded rpo B gene (McConkey et al., 1997) . The large subunit rRNA (LSU rRNA) is apicoplast encoded and its guanosine triphosphatase (GTPase)-binding domain (ribosomal L11 protein) is responsible for apicoplast translation. The apicoplast translation is inhibited with thiostrepton (McConkey et al., 1997) , which also perturbs the proteasome and mitochondria in Babesia (Aboulaila et al., 2012) . Pharmaceutical disruption of the genes responsible for the bacterial housekeeping machinery of the apicoplast of Babesia parasites was successfully achieved in vitro by ciprofloxacin, thiostrepton, and rifampicin (AbouLaila et al., 2012) . In this study, we present the results of molecular disruption of DNA gyrase Subunit A, DNA gyrase subunit B, ribosomal L11, and rpoB genes in Babesia bovis by the RNA interference (RNAi) using double stranded RNA (dsRNA) of target genes.
MATERIALS AND METHODS Parasite
Babesia bovis (B. bovis) Texas strain (Hines et al., 1995) was grown in a micro-aerophilous stationary phase culture system using bovine erythrocytes (RBCs) and GIT medium (Wako Pure Chemicals, Osaka, Japan) (AbouLaila et al., 2010) . DNA extraction, PCR amplification, and Double-stranded RNA in vitro synthesis B. bovis-infected RBCs with 5 % parasitemia were collected from the culture and washed three times with cold phosphate-buffer saline (PBS) by centrifuging at 1000×g for 5minutes at 4 ºC. DNA was extracted from 200 µl infected RBCs using QiAmp DNA Blood Mini kit (QIAGEN, Tokyo, Japan) according to the manufacturer's protocol. DNA concentration was measured using Nano Drop 2000 spectrophotometer (Thermo Fisher Scientific Inc., USA). Primers used in this study were designed based on the sequences of DNA gyrase subunit A, DNA gyrase subunit B, ribosomal protein L11 (Thiostrepton interaction site on the LSU rRNA), rpo B genes, and the sequence of pEGFPn1 plasmid (gene bank accession numbers: XM_001609478, XM_001611055, XM_001610852, XM_001609672, and U55762). For primer design, the amino acid sequences of DNA gyrase subunit A and B and the rpo B were blasted at the protein blast tool at the NCBI to get the active domains of the enzymes ( Fig.1 A, a) . The gyrase A forward primer 5´-GTAATACGACTCACTATAGGTCTGGAGCT GTGCGACGAAC-3´ and reverse primer 5´-GTAATACGACTCACTATAGGTATGTGCT CTAATTCGCTGTA-3´ were used to amplify the nucleotides 300 to 1800 of the DNA gyrase A subunit gene and designed as gyrase A (Fig.1) . The gyrase B forward primer 5´-GTAATACGACTCACTATAGG ACTGCGGCTAGTGGATGAAC-3´ and reverse-primer-5´-GTAATACGACTCACTATA GGTGACTGCACGTCTCCACCCATG-3´ were used to amplify the nucleotides 1200 to 2775 of the DNA gyrase subunit B gene and designed as gyrase B (Fig.1 A) . For the rpo B gene, rpo B1 and B2 were selected as target sequences (Fig.1 ). The rpo B1 forward 5´-GTAATACGACTCACTATAGGATGGAGTT CAATGTTACCG-3´ and rpo B1 reverse 5´-GTAATACGACTCACTATAGGTCCACAA GGGGCGCCATCAG-3´ primers were used to amplify the nucleotides 1 to 1650 of the rpo B gene. The rpo B 2 F 5´-GTAATACGACTCACTATAGGAGAAGCTA GAATATCTCACC-3´ and rpo B2 R 5´-GTAATACGACTCACTATAGGACTGTCTA TAGGAAGACCCAATT-3´ primers were used to amplify the nucleotides 2100 to 3849 of the rpo B gene (Fig.1 ). Ribosomal protein L11 (thiostrepton interaction site) F 5´-GTAATACGACTCACTATAGGATGAAGTT TCTTGGAAGATACC-3´ and R 5´-GTAATACGACTCACTATAGGCTACTTTT TCCCGCGTTTCTGC-3´ primers were used to amplify the nucleotides 1 to 537 of the ribosomal protein L11 (thiostrepton interaction site) gene. To confirm the specificity of the RNAi mediated by the DNA gyrase A and B, L11, and rpo B1 and B2 dsRNAs, a sequence of GFP at position 672 to 1388 from pEGFPn1 plasmid was amplified by the forward primer 5´-GTAATACGACTCACTATAGGATGGTGA GCAAGGGCGAGGAG-3´ and reverse primer-5´-GTAATACGACTCACTATAGGTTA CTTGTACAGCTCGTCCA-3´. All the primers have the T7 promoter (underlined) at their 5´ end to permit the in vitro transcription of the RNA strands by the T7 enzyme. PCR was performed in 100 µl of a mixture containing 200 ng of the extracted DNA template, 500 nM of each primer, 200 µM of each dNTP, and 5 U of Taq Gold DNA polymerase (Applied Biosystems, Foster City, CA, USA) in a PCR buffer (Applied Biosystems). The reactions were performed at the following temperatures: initial denaturation at 95°C for 5 minutes to activate the Taq Gold DNA polymerase followed by 35 cycles (1 minute of DNA denaturation, 1 minute of primer annealing (at 65 °C (gyrase A), 64 °C (gyrase B), 60.5 °C (ropB1), 57 °C (ropB2), 59.4 °C (L11), and 55 °C (GFP), and extension at 72°C 1 (L11 and pEGFPN1), 1.5 (gyrase A) and for 2 minutes (gyrase B, rpo B1, and rpo B2), and final extension at 72 °C for 7 minutes in a Veriti® 96-Well Thermal Cycler (Applied Biosystems, USA). The PCR products were subjected to electrophoresis in 2 % agarose gel and then visualized under an ultraviolet (UV) light and stained with eithedium bromide (Sigma-Aldrich). The PCR products were purified using QIAquick PCR purification kit (QIAGEN, Tokyo, Japan). The concentration of the purified products was quantified using Nano Drop 2000 spectrophotometer (Thermo Fisher Scientific Inc., USA). The dsRNA was synthesised from about 1 µg of each of the purified PCR products of gyrase A, gyrase B, rpo B1, rpo B2, L11, and GFP using T7 RiboMAX Express RNAi system (Promega, Madison, USA) according to the manufacturer's instructions. The dsRNA was resuspended in 0.1 % diethylpyrocarbonate (DEPC) treated water. The purity of synthesized dsRNA was checked by 1 % agarose gel electrophoresis and the concentration was quantified by spectrophotometer (Thermo Fisher Scientific Inc., USA). The dsRNA aliquots were stored in -80 º C until used.
RNAi in vitro growth inhibition assay
The in vitro growth inhibition assay for RNAi followed a method previously described (AbouLaila et al., 2010; Malhotra et al., 2002) with some modifications. Parasite-infected RBCs were diluted with uninfected RBC to obtain 1% parasitemia. Twenty µl of RBC with 1% parasitemia was dispensed to a 96-well microtiter plate together with 200µl of the culture medium containing the indicated concentration of double stranded RNA (dsRNA) (10 and 50 µg/ml for gyrase A, gyrase B, L11, rpo B1, and rpo B2). A mixture of 10 µg/ml of each of gyrase A and gyrase B and another mixture of 10 µg/ml of each rpo B1 and rpo B2 were used. Then, plates were incubated at 37°C in a humified multi-gas water-jacketed incubator. For the negative control, cultures without the dsRNA containing only DEPC treated water and another containing a control dsRNA for GFP (Gong et al., 2008) in a similar concentration like the highest concentration were prepared. For the positive control, cultures containing ciprofloxacin, thiostrepton, and rifampicin at a concentration of 50 µg/ml were used. The experiments were carried out in triplicate for 3 separate trials for a period of four days. The culture medium was replaced daily with 200 µl of a fresh medium containing the appropriate concentration of the dsRNA. Parasitemia was monitored daily by counting the parasitized RBCs to 1,000 in Giemsa-stained thin blood smears. Morphological changes in the parasites from treated cultures were reported by light microscope.
Confirmation of gene silencing by reverse transcription PCR (RT-PCR)
B. bovis was cultured in 24 well culture plates in bovine RBCs and GIT medium. The culture was treated with 100 µg/ml of dsRNA of gyrase A, gyrase B, ribosomal protein L11, rpo B1 and B2 and a control GFP dsRNA in triplicate for 2 days. RBCs were collected and washed with PBS. The total RNA was extracted using TRI® reagent (Sigma-Aldrich, USA) according to the supplied protocol. The RNA concentration was measured using spectrophotometer (Thermo Fisher Scientific Inc., USA). The RT PCR was conducted using the PrimeScript TM One-Step RT-PCR kit (Takara, Japan) according to the manufacturer's protocol. 150 ng of total RNA from the treated cultures and from the control were used in the amplification of the target sequences with the specific primers for the targeted sequences that were used in the PCR reactions above (this study) and for the full length DNA gyrase subunit A, DNA gyrase subunit B, L11 protein, and rpo B genes (AbouLaila et al., 2012) . Gyrase A forward primer 5´-CTGGTTTATTATATATGAACCC-3´ and reverse primer 5´-CATTTTAGCAAAT ATTAGTTA-3´ were used to amplify the DNA gyrase subunit A. Gyrase B forward primer 5´-CCCGCCTCACTGCTACTGGCAGATG-3´ and reverse primer 5´-CTACCTATCTAGGTCATGTAGC-3´ were used to amplify the DNA gyrase subunit B. and reverse 5´-CCAAGGACCTTCAACGTACGAGGTCA-3´ primers (Figueroa et al., 1993) were used as controls for the transcription of the targeted genes from the dsRNA treated and GFP control cultures. The reverse transcription reaction was carried out at 50°C for 30 minutes, and then PCR was repeated for 30 cycles under the following conditions: 30 seconds on denaturation at 94 °C , 30 seconds of primer annealing (at 50 °C gyrase A, 62 °C gyrase B, 59.4 °C L11, 56 °C rpo B, 55 °C RAP-1, 57 °C ssrRNA and 54°C tubulin beta chain), and elongation at 72 °C for 0.45 (L11 and RAP-1 ), 2 (tubulin beta chain and ssrRNA), 3 (gyrase A and B), , and 4 (rpo B) minutes. The PCR products were subjected to electrophoresis in 2 % agarose gel and stained with eithedium bromide.
Statistical analysis
JMP statistical software version 5.1(SAS Institute Inc., USA) was used to compare the means in the in vitro inhibition assay by one way analysis of variance (ANOVA) followed by all pairs Tuckey-Kramer HSD and considered to be significantly different when P < 0.01.
RESULTS AND DISCUSSION PCR and dsRNA production
Target sequences of 1501, 1576, 1650, 1750, 538, and 716 bp specific for gyrase A, gyrase rpo B1, rpo B2 and GFP were successfully amplified with PCR (data not shown).. The in vitro transcription using T7 enzyme resulted in target specific dsRNA of 1501, 1576, 1650, 1750, 538, and 716 bp for each of gyrase A, gyrase B, rpo B1, rpo B2, L11, and GFP genes, respectively (Fig.1) . In vitro growth inhibition assay B. bovis growth (Fig. 2) from an initial parasitemia of 1% was significantly (ANOVA) inhibited at 10 µg/ml and 50 µg/ml concentrations of gyrase A, gyrase B, rpo B1 and B2, and L11 (Fig. 2) . Treatment with a mixture formed of 10 µg/ml gyrase A and 10 µg/ml gyrase B significantly inhibited the growth (ANOVA, P < 0.01). The mixture formed of 10 µg/ml rpo B1 and 10 µg/ml rpo B2 resulted in significant inhibition of the growth (ANOVA, P < 0.01) (Fig. 2) . The single treatment with 10 µg/ml or 50 µg/ml of each of the dsRNA of gyrase A, gyrase B, rpo B1, rpo B2, and L11 (Tukey-Kramer HSD) did not show significant difference. There was no significant difference between the single treatment with 10 µg/ml or 50 µg/ml of each dsRNA and the mixture formed of 10 µg/ml gyrase A and 10 µg/ml gyrase B dsRNAs and the mixture formed of 10 µg/ml rpo B1 and 10 µg/ml rpo B2 dsRNAs (Tukey-Kramer HSD) (Fig. 2) . Ciprofloxacin, thiostrepton, and rifampicin at a 50 µg/ml concentration significantly suppressed the growth on the first day of culture than the control and dsRNA treatments.
Light microscope observation showed that the treatment with dsRNA of gyrase A (Fig. 3B ), gyrase B (Fig. 3  C) , gyrase A and B mixture (Fig. 3D ), L11 ( Fig.  3 E) , rpo B1 ( Fig.3 F) , rpo B2 ( Fig. 3 G) , and rpo B1 and rpo B2 mixture ( Fig. 3 H) resulted in morphological changes in the treated parasites than the GFP dsRNA control cultures. Parasites in treated cultures appeared degenerated without cytoplasm, swollen, and there was a high numbers of abnormally multidividing forms (Fig. 3) .
RT-PCR
B. bovis cultures treated with 100 µg/ml dsRNA of gyrase A, gyrase B, L11, rpo B1 and B2, and GFP for 2 days; then, reverse transcription PCR for total RNA extracted from these cultures showed that the transcription of gene of DNA gyrase subunit A ( Fig. 4 A, lane 2) , DNA gyrase subunit B (Fig.  4 A, lane 6) , rpo B ( Fig. 4 A, lane 14) , and ribosomal L11 protein ( Fig. 4 B, lane 2 ) genes was inhibited than in the GFP dsRNA control (Fig.5A, lanes 1, 5, B, lanes, 1, 5 , and C, lane 1 ). Dissimilarly, the transcription of B. bovis tubulin beta chain gene was not affected by the dsRNA treatment (Fig. 4 A,  lanes 4, 8, B, lane 4, 8 , and C, lane 4) than in the GFP dsRNA control culture (Fig. 4A,  lanes 3, 7, B, lane 3, 7, and C, lane 3) . Rap-1 transcripts were not affected by the dsRNA treatment (Fig.4A, lanes 11, 13, B lanes 9, 15, and C, lane 5) than in GFPdeRNA control (Fig.4A, lanes 12, 14, B lanes 10, 16, and C, lane 6). Transcripts of ssrRNA gene were not affected by the dsRNA treatment (Fig.5A, lanes 9, 15,  B lanes, 11, 13 and C, lane 7) than GFPdeRNA control culture (Fig.4A, lanes 10,  16, B lanes, 12, 14 and C, lane 8) . RT-PCR using specific primers for the target sequences showed no transcription of the targeted sequences of gyrase A, gyrase B, rpo B1, rpoB2, and ribosomal L11 protein. In contrast, transcripts of tubulin beta chain, rap-1, and ssrRNA gene were not affected by dsRNA treatments. In the present study, we attempted RNAi in Babesia bovis, an intracellular parasite using dsRNAs for DNA gyrase, DNA-directed RNA polymerase beta subunit, and thiostrepton interaction site (ribosomal L11 protein). These genes were targeted by ciprofloxacin, rifampicin, and thiostrepton leading to inhibition of B. bovis growth (AbouLaila et al., 2012) . Inhibition of B. bovis growth by in vitro treatment with the dsRNA of gyrase A, gyrase B, L11 protein, rpo B1 and B2 genes was revealed. All the concentrations of dsRNA resulted in significant inhibition of B. bovis growth. Alternatively, no significant difference was observed among the treated culture with 10 µg/ml and 50 µg/ml. treatment with dsRNA targeting the 2 targeted sequences of rpo B, rpo B1 and B2, either alone at 10 µg/ml or in a mixture formed of 10µg/ml of each of them could not produce significant differences. Similarly, treatment with dsRNA at 10 µg/ml for gyrase A or gyrase B was similar to the mixture formed of 10 µg/ml of each the dsRNA to silence the DNA gyrase. This might be owing to silencing a part of gene by RNAi leads to the destruction of the whole gene transcript and this in a good agreement with Hatta et al., (2007) , who silenced the whole gene encoding cytosolic leucine aminopeptidase of the Hemaphysalis longicornis by dsRNA of a partial-length N-terminal domain of the gene. Treatment with dsRNA of GFP from pEGFPn1 and DEPC treated water had no effect on B. bovis growth indicating that the inhibitory effect was due to treatment with dsRNA of gyrase A, gyrase B, L11, and rpo B1and B 2. The dsRNA treatment resulted in sever morphological changes in the parasites from treated cultures, but not in the parasites from DEPC DW or a non-specific GFP dsRNA treated cultures, indicating specific inhibition of B. bovis by RNAi. (lanes 1, 5, 9, and 13 ). (C) DsRNA treatment of thiostrepton interaction site (ribosomal L11 protein) (lane 2) and GFP dsRNA control (lane 1). Tubulin beta chain (A and  B, lanes 3,4,7,8 and C, lanes 3, 4) , rap-1 (A, lanes 11,12, 13, 14, B, lanes 9, 10, 15, 16, and C, lanes 5, 6) , and ssrRNA (A, lanes 9, 10, 15, 16, B, lanes11,12, 13, 14, and C, lanes 7 , 8) genes from dsRNA-treated and dsRNA of GFP-treated cultures. M is molecular weight marker.
We also compared the effects produced by DNA gyrase, L11, and rpo B dsRNAs on B. bovis parasites with the effects of ciprofloxacin, thiostrepton, and rifampicin, well-known inhibitors of DNA gyrase, apicoplast translation, and rpo B, respectively. Our study showed that dsRNA treatment reduced the growth but the inhibition was lower than the inhibition resulted from drug treatments. This might be due to dsRNA was not able to enter through cell wall and only the small molecules were able to penetrate into the cells, resulted from its break down in the medium. The results are covenant with previous study on plasmodium falciparum (Malhotra et al., 2002) as RNAi using dsRNA not completely eliminate the parasites that might be as a result of technical limits of the technique. The gene silencing by the RNAi was confirmed by RT-PCR. The inhibitory effects produced by dsRNA treatment of parasites coincided with a marked reduction in the levels of endogenous mRNA homologous to the dsRNA in these parasites, which is a characteristic feature of RNAi. The RT reactions from parasite cultures treated with dsRNA of gyrase A, gyrase B, L11, rpo B1, and rpo B2 showed that no amplifications were reported for either the target sequences or full length genes of DNA gyrase subunit A, DNA gyrase subunit B, L11, rpo B indicating the disruption of the mRNA transcripts of these genes by the RNAi. In contrast, the control tubulin beta chain, rap-1, and ssrRNA genes were successfully amplified from the dsRNA treated cultures indicated that the mRNA transcripts for tubulin beta chain, rap-1, and ssrRNA were not affected; therefore, the dsRNA treatment is specific for the targeted genes. The DNA gyrase subunit A, DNA gyrase subunit B, L11, rpo B were successfully amplified by the RT PCR from GFP dsRNA control cultures as well as the tubulin beta chain, rap-1, and ssrRNA controls; therefore, the RNAi is specific effective tool in the disruption of gene functions in B. bovis. In this study, we used in vitro dsRNA disruption of B. bovis and this method depends on the uptake of the dsRNA by the parasites and our results were in covenant with the in vitro dsRNA disruption of P. falciparum (Malhotra et al., 2002) . Furthermore, the results of the present study is consistent with previous RNAi studies including soaking of whole C. elegans (Tabara et al., 1998) and Brugia malayi (Aboobaker and Blaxter, 2003) in a solution containing dsRNA or the in vitro incubation of Drosophila S2 cells with dsRNA (Clemens et al., 2000) , all showing the ability of dsRNA to cross cell boundaries and pass through several types of tissues. The use of RNAi in B. bovis has several advantages over other methods requiring the introduction of DNA into cells. Transfection experiments require more knowledge of the full gene sequence and its flanking regions while dsRNA corresponding to any gene fragments is sufficient to produce the interference effect in the RNAi (Ullu and Tschudi, 2000) . Furthermore, the use of RNAi is technically simple and quick achieving results within 2-3 days. On the other hand, selective gene 'knock-outs' by transfection technology requires longer time. RNAi in B. bovis also provides a tool for studying the functions of a number of genes together, as shown in the present study. With the availability of a large amount of sequence information for B. bovis, RNAi-based functional genomics might be a useful technique for investigating the biological functions of novel genes. Finally, given the gene-specific feature of RNAi and the ease of inducing RNAi, this methodology may also play a role in the development of therapeutic applications against Babesia infections. The discovery of RNAi is one of the marvelous advances in molecular genetics in the last decade (Fjose et al., 2001; Yu et al., 2009) . RNA interference (RNAi) is becoming an increasingly powerful post-transcriptional gene silencing (PTGS) technique that is providing insight into gene function (Elbashir et al., 2001; Hannon, 2002) and consequently the reliability of gene identity rose by homology search of the databases. The
RNAi process involves an ATP-dependent production of small, ≈ 21-25 nt, interfering RNA molecules (siRNAs) from double stranded RNA (dsRNA) and is believed to be responsible for targeting and destroying specific mRNAs facilitated by the formation of the RNA-induced silencing complex (RISC) (Moissiard et al., 2006) . The RISC RNA molecules complementary to the mRNAs seem to work as a guide recruiting a ribonuclease that consequently cleaves only specific mRNAs (Aigner, 2008; Grishok et al ., 2001) . RNAi is a two-step mechanism and both mechanisms and the components of dsRNA-induced gene silencing in a diverse group of organisms are conserved. Two sets of genes coding for proteins implicated in RNAi have been identified in different organisms. The first set of proteins is the one with homology to tomato RNA-directed RNA polymerase (RdRP): Neurospora QDE-1, C.
elegans
EGO-1 and Araabidopsis SGS-2/SDE-1. The second set of proteins involved in RNAi includes Arabidopsis AGO-1, Neurospora QDE-2 and C. elegans RDE-1 (Malhotra et al., 2002; Fagard et al., 2000; Elbashir et al., 2001; Grishok et l., 2001; Lee et l., 2010) . Some related sequences were reported in P. falciparum through the blast search tool at the PlasmoDB.org (Malhotra et al., 2002) . Instead, some recent studies mentioned that RNAi pathway important components for instance Dicer and Argonaute genes are absent from P. falciparum (Atayde et al., 2011; Baum et al., 2009; Kolev et al., 2011; Xue et al., 2008) . Furthermore, no related sequences were detected by blast search of the sequences of these genes with the B. bovis server at www.sanger.ac.uk/cgi-bin/blast/submitblast/b _bovis and this is compatible with Batista and Marques, (2011) ; therefore, further studies are required for the understanding of the mechanism of RNAi by dsRNA in Babesia parasites In conclusion, the present study shows that the RNAi technique disrupted the transcripts of targeted genes and affected the growth of parasites; however, the machinery in B. bovis required further studies to be elucidated.
